Researches and develops innovative prescription medicines across various therapeutic areas. Manufactures and markets a broad portfolio of healthcare products globally. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
The gap is $25.4B. In times of high interest rates, a gap like that can squeeze a company.
The market pays 18.5× for every dollar of annual profit — around what a business like this usually costs.
Against companies in its own sector, it looks cheaper than 58% of them.
Analysts' average target sits 12% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
Clearly below the class average.
The price isn’t cheap next to earnings — that’s why this grade sits in the middle.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly below the class average.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
The stock trades 19% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 26% — still a thick cushion, though costs have been eating into it lately.
It pays out $4.74 per share each year — regular cash for whoever holds the stock.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 44/100.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 49/100. For a turnaround signal, the stock first needs to close the gap with the market.
On our five-subject report card, NVS sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: NVS is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s what that quality should cost.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.